Palvella Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, LLC | 05/15/2025 | 714.46 K | $20.00 M | 0.00% | 32.10% |
| BVF INC/IL | 05/15/2025 | 696.56 K | $19.50 M | 0.00% | 31.29% |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 05/15/2025 | 690.01 K | $19.31 M | 5.52% | 31.00% |
| SAMSARA BIOCAPITAL, LLC | 05/15/2025 | 679.49 K | $19.02 M | 0.00% | 30.53% |
| ADAMS STREET PARTNERS LLC | 05/14/2025 | 409.67 K | $11.47 M | 0.00% | 18.40% |
| MILLENNIUM MANAGEMENT LLC | 05/15/2025 | 269.84 K | $7.55 M | 100.00% | 12.12% |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 05/15/2025 | 250.06 K | $7.00 M | 0.00% | 11.23% |
| WOODLINE PARTNERS LP | 05/15/2025 | 194.17 K | $5.43 M | 100.00% | 8.72% |
| OPALEYE MANAGEMENT INC. | 05/15/2025 | 172.36 K | $4.82 M | 100.00% | 7.74% |
| BLUE OWL CAPITAL HOLDINGS LP | 05/15/2025 | 140.26 K | $3.93 M | -43.91% | 6.30% |
| VANGUARD GROUP INC | 05/09/2025 | 138.43 K | $3.87 M | 1,120.53% | 6.22% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/14/2025 | 114.39 K | $3.20 M | 100.00% | 5.14% |
| BLACKROCK, INC. | 05/02/2025 | 110.76 K | $3.10 M | 756.07% | 4.98% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 94.20 K | $2.64 M | 560.12% | 4.23% |
| ROYCE & ASSOCIATES LP | 05/06/2025 | 71.51 K | $2.00 M | 100.00% | 3.21% |
| AWM INVESTMENT COMPANY, INC. | 05/15/2025 | 69.42 K | $1.94 M | 100.00% | 3.12% |
| UBS OCONNOR LLC | 05/15/2025 | 48.66 K | $1.36 M | 100.00% | 2.19% |
| DAFNA CAPITAL MANAGEMENT LLC | 05/15/2025 | 43.35 K | $1.21 M | -39.33% | 1.95% |
| MARSHALL WACE, LLP | 05/15/2025 | 30.35 K | $849.36 K | 100.00% | 1.36% |
| STRID GROUP, LLC | 04/25/2025 | 29.22 K | $817.84 K | 100.00% | 1.31% |
| CRESSET ASSET MANAGEMENT, LLC | 05/13/2025 | 20.91 K | $585.30 K | 0.00% | 0.94% |
| GOLDMAN SACHS GROUP INC | 05/16/2025 | 19.05 K | $533.29 K | 100.00% | 0.86% |
| TORONTO DOMINION BANK | 05/15/2025 | 18.87 K | $528.23 K | 42.85% | 0.85% |
| NORTHERN TRUST CORP | 05/13/2025 | 16.64 K | $465.61 K | 100.00% | 0.75% |
| RENAISSANCE TECHNOLOGIES LLC | 05/14/2025 | 15.26 K | $427.07 K | -28.60% | 0.69% |
| DELTEC ASSET MANAGEMENT LLC | 04/22/2025 | 12.50 K | $349.88 K | 0.00% | 0.56% |
| STATE STREET CORP | 05/15/2025 | 12.06 K | $337.62 K | 100.00% | 0.54% |
| UBS GROUP AG | 05/13/2025 | 10.05 K | $281.41 K | 4,877.23% | 0.45% |
| MORGAN STANLEY | 05/15/2025 | 9.91 K | $277.30 K | 10,786.81% | 0.45% |
| BALYASNY ASSET MANAGEMENT L.P. | 05/15/2025 | 8.18 K | $228.85 K | 100.00% | 0.37% |
| BANK OF AMERICA CORP /DE/ | 05/15/2025 | 7.61 K | $212.98 K | 63,308.33% | 0.34% |
| SPIRE WEALTH MANAGEMENT | 04/23/2025 | 2.52 K | $70.42 K | 100.00% | 0.11% |
| CITIGROUP INC | 05/12/2025 | 2.25 K | $62.87 K | 102.71% | 0.10% |
| GROUP ONE TRADING, L.P. | 05/14/2025 | 312 | $8.73 K | 0.00% | 0.01% |
| BARCLAYS PLC | 05/15/2025 | 63 | $1.00 K | 0.00% | 0.00% |
| WELLS FARGO & COMPANY/MN | 05/13/2025 | 50 | $1.40 K | 0.00% | 0.00% |
| TRUVESTMENTS CAPITAL LLC | 05/14/2025 | 14 | $392 | 0.00% | 0.00% |
| ALLWORTH FINANCIAL LP | 04/30/2025 | 5 | $128 | 0.00% | 0.00% |
| JPMORGAN CHASE & CO | 05/12/2025 | 3 | $84 | -88.46% | 0.00% |
| JONES FINANCIAL COMPANIES LLLP | 05/28/2025 | 3 | $84 | 0.00% | 0.00% |
| US BANCORP \DE\ | 05/08/2025 | 0 | $0 | -100.00% | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 05/21/2025 | 0 | $0 | -100.00% | 0.00% |
| CITADEL ADVISORS LLC | 05/15/2025 | 0 | $0 | -100.00% | 0.00% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 05/15/2025 | 0 | $0 | -100.00% | 0.00% |
| BML CAPITAL MANAGEMENT, LLC | 05/07/2025 | 0 | $0 | -100.00% | 0.00% |
| ADVISOR GROUP HOLDINGS, INC. | 05/12/2025 | 0 | $0 | -100.00% | 0.00% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 05/15/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Palvella Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 48 institutional investors and hedge funds held shares of Palvella Therapeutics, Inc.. The most heavily invested institutionals were:
SUVRETTA CAPITAL MANAGEMENT, LLC: 714,463
BVF INC/IL: 696,555
Frazier Life Sciences Management, L.P.: 690,012
Samsara BioCapital, LLC: 679,486
ADAMS STREET PARTNERS LLC: 409,666
MILLENNIUM MANAGEMENT LLC: 269,837
230.17% of Palvella Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 5.14 M shares in the last 24 months. This purchase volume represents approximately $109.76 M in transactions.